Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 2nd article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Professor Seebacher, a leading dermatomycologist, always warned us never to end onychomycosis therapy too early. Here are the reasons: Mycosis does not confer immunity. But, above all, […]
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 1st article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Mycology is one of the most beautiful faces of dermatology. To admire T. soudanense, T. violaceum or T. benhamiae in a Petri dish is an aesthetic enjoyment.
It all started at a market in Wuhan, China. Within a few weeks, a novel coronavirus, now called 2019-nCoV, spread to at least 15 regions or countries outside of the Chinese mainland. In December 2019, the WHO China Country Office was informed of cases of pneumonia of unknown aetiology (unknown cause) detected in Wuhan City,
Five years ago, the ICAP initiative on harmonisation and standardisation in the nomenclature of HEp-2 IFA patterns was implemented at the International Workshop on Autoantibodies and Autoimmunity (IWAA) in São Paulo, Brazil. Luis E. C. Andrade, professor at the Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, has been involved from the
This autumn, cases of West Nile virus and Zika virus infections due to transmission by infected mosquitoes have occurred locally for the first time in Germany and France. These cases of locally acquired infections are also named autochthonous cases. Several infectious agents, some of them just newly identified, have spread globally over the past years,
